Filed before 2025Filed 26 October 2020
A2 Biotherapeutics, Inc. has sold $71.5M so far
A2 Biotherapeutics, Inc., a biotech company based in Agoura Hills, CA, has sold $71.5M so far in its equity round, according to a filing dated 26 October 2020.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 26 October 2020
- First filed
- 20 October 2020
- Round
- Equity round (amended filing)
- Amount sold
- $71.5M
- Offering size
- $71.5M
- Investors so far
- 13
- Based in
- Agoura Hills, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
4 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 92% of the 1,744 tracked raises with an amount filed in 2020, and than 81% of the 152 in biotech.
A2 Biotherapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 16 Dec 2022 | Amended filing | $71.6M | Another raise |
| 17 Nov 2022 | New filing | $60.9M | Another raise |
| 26 Oct 2020 | Amended filing | $71.5M | This raise |
| 20 Oct 2020 | New filing | $58M | This raise |
More with Ponoi Capital on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.